Formulation and Evaluation of Buccal Disintegrating Tablet Containing Anticonvulsant Drug

Authors

  • Akshay. M. Akotkar
  • Nidhi Bais
  • Sachin Jain

Keywords:

gabapentine buccal tablet, treatment convulsant disease with B Cyclodextrin

Abstract

The oral and buccal routes are widely recognized as the most convenient and patient-friendly methods of drug administration, offering ease of use, safety, and improved compliance. Buccal disintegrating tablets provide an advantage over conventional dosage forms, especially for patients who experience difficulty in swallowing, such as those with dysphagia, motion sickness, or neurological conditions. These tablets dissolve rapidly in saliva without the need for water, ensuring quick onset of action and ease of administration.

The present study focuses on the formulation and evaluation of buccal disintegrating tablets of Gabapentin, an anticonvulsant drug, using β-Cyclodextrin to enhance its solubility and stability. β-Cyclodextrin is a well-established pharmaceutical excipient known for improving the solubility of poorly water-soluble drugs through complexation. Various formulations were prepared using the direct compression method, and the tablets were evaluated for physicochemical parameters including disintegration time, drug release profile, and mechanical properties.

Among the different formulations tested, formulation F5 exhibited the most promising results, with rapid disintegration and a high drug release rate of 99.99%. The study concludes that β-Cyclodextrin-based buccal disintegrating tablets of Gabapentin are a viable alternative for enhancing bioavailability and improving patient compliance..

Downloads

Download data is not yet available.

References

Surender Verma and Mahima Kaul “AN OVERVIEW ON BUCCAL DRUG DELIVERY SYSTEM” IJPSR, 2011; Vol. 2(6): 1303-1321.

Akshay. M. Akotakar , Ashwini. A. Zanke “Formulation and Evaluation of Buccal Disintegrating Tablet of Anticonvulsant Drug” Asian Journal of Research in Pharmaceutical Sciences. 12(2): April - June, 2022.

Rameshwari S, Jeya Anandhi J Arulmigu Kalasalingam College Of Pharmacy, Tamilnadu Asian Journal Of Pharmaceutical And Clinical Research July-September 2009; 2(3). Issn 0974-2441.

Gandhi Sd, Pandya Pr, Umbarkar R, Tambawala T And Shah Ma. Mucoadhesive Drug Delivery System- An Unusual Maneuver For Sitespecific Drug Delivery System, Inter. J. Pharm. Sci., 2011, 851- 872.

K. Naga Raju, S.Velmurgan, B. Deepika, Sundar Vinushitha, Klr Pharmacy College, Poloncha, Andhra Pradesh, International Journal Of Pharmacy& Pharmaceutical Science, Volume 3,2011, Page No. 239-246.

N. S. Miller, M. Chittchang, T. P. Johnston. The Use Of Mucoadhesive Polymers In Buccal Drug Delivery. Adv Drug Delivery Review.2005; 57:1666- 91.

Khanna R, Agarwal Sp, Ahuja A. Mucoadhesive Buccal Drug Delivery: A Potential Alternative To Conventional Therapy. Indian Journal Of Pharmaceutical Science 1998;60(L):1-11.

Khairnar Ga, Sayyad Fj. Development Of Buccal Drug Delivery System Based On Mucoadhesive Polymers. International Journal Of Pharmtech Research. 2010; 2(1): 719-735.

Prof. F. R. Sheeba ,“Beta-Cyclodextrin As An Excipient In Drug Formulation” Asian Journal of Pharmaceutical Research and Development. 2021; 9(4): 122-127.

Mr. K. Govindasamy Formulation And Evaluation Of Gabapentin Oral Controlled Release Matrix Tablets Submitted To The Tamil Nadu Dr. M.G.R. Medical University Chennai – 32 In The Department Of Pharmaceutics Reg. No: 26106811,Page No.54.

Mr. K. Govindasamy Formulation And Evaluation Of Gabapentin Oral Controlled Release Matrix Tablets Submitted To The Tamil Nadu Dr. M.G.R. Medical University Chennai – 32 In The Department Of Pharmaceutics Reg. No: 26106811,Page No.60.

Shraddha R Nagpure, Prerana B Jadhav. Formulation Development and Evaluation of Gabapentin Buccal Tablets International Journal of Innovative Pharmaceutical Sciences and Research 2018, 6 (06), 13-22 Issn (Online) 2347-2154.

Http://Drugbank.Ca/Drugs/Db00996(Aprd00015)

K. Govindasamy. Formulation and Evaluation of Gabapentin Oral Controlled Release Matrix Tablets Submitted to The Tamil Nadu Dr. M.G.R. Medical UniversityChennai – 32 In The Department Of Pharmaceutics Reg. No: 26106811, Page No.54.

K. Govindasamy. Formulation and Evaluation of Gabapentin Oral Controlled Release Matrix Tablets Submitted to The Tamil Nadu Dr. M.G.R. Medical UniversityChennai – 32 In The Department Of PharmaceuticsReg. No: 26106811, Page No.60.

K. Govindasamy. Formulation and Evaluation of Gabapentin Oral Controlled Release Matrix Tablets Submitted To The Tamil Nadu Dr. M.G.R. Medical UniversityChennai – 32 In The Department Of Pharmaceutics Reg. No: 26106811, Page No.52.

Timmermans J, Moes AJ. Factors Controlling The Buoyancy And Gastric Retentioncapabilities Of Floating Matrix Capsules. New Data For Reconsidering The Controversy. J. Pharm. Sci. 1994; 83: 18-24

Swetha. Koorapati. Formulation And In Vitro Evaluation of Gastroretentive Dosage Form Of Gabapentin. Submitted To The Tamil Nadu Dr. M.G.R. Medical University, Chennai Reg.No:26103014, Page No. 110.

Kenneth E. Avis, Herbert A. Lieberman, And Leon Lachman. Pharmaceutical Dosage Forms, Tablets, 3 Rd Edition, Published By: Marcel Dekker, Vol-1, 42- 56.

Waldwell, L.J; Gardner. C.R; Cargil, R. C; Us Patent 4, 1988; 735,804.

Doddayya Hiremath Et AL. Formulation and Evaluation of Controlled Release Matrix Tablets Of Ambroxol Hydrochloride. Journal Of Pharmacy Research. 2010; 3(8),1810-1813.

Pimlott SJ, Addy M. Site Dependent Absorption Study on Buccal Mucosae. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 1985; 59:145-48.

Robinson JR. Sustained and Controlled Release Drug Delivery System, 2nd Edition, Published By: Marcel Dekker, 138-171...

Downloads

Published

2025-06-15

How to Cite

1.
Akotkar AM, Bais N, Jain S. Formulation and Evaluation of Buccal Disintegrating Tablet Containing Anticonvulsant Drug. J Neonatal Surg [Internet]. 2025Jun.15 [cited 2025Jul.20];14(32S):257-66. Available from: https://jneonatalsurg.com/index.php/jns/article/view/7358

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.